tirzepatide before and after 12 weeks vs. Semaglutide for Weight Loss: What I Learned, What Worked, What Didn't ~ Tirzepatide Weight Loss Journey: Our
Description
Patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use GLP-1 receptor agonists due to thyroid C-cell tumor risk observed in animal studies
We do not accept or bill insurance
Participants completed original and adapted forms of validated assessments (see Supplemental document)
E.ScheuerT.CatterallW
The Bottom Line Ozempic produces meaningful weight loss for most people who take it consistently
J Am Coll Cardiol 2021;77:1381-92
